Business Description
Big Pharma Split Corp
NAICS : 523930
SIC : 7214
ISIN : CA08934P1080
Share Class Description:
FRA:XN4: Class ADescription
Big Pharma Split Corp is a closed end mutual fund corporation. The investment objective of the company is to provide shareholders with fixed cumulative preferential quarterly cash distributions and regular monthly cash distributions. The company has a presence in the United States, France, and the United Kingdom.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.6 | |||||
3-Year EPS without NRI Growth Rate | 31.5 | |||||
3-Year Book Growth Rate | -3.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.48 | |||||
9-Day RSI | 41.29 | |||||
14-Day RSI | 44.79 | |||||
3-1 Month Momentum % | 8.33 | |||||
6-1 Month Momentum % | -11.73 | |||||
12-1 Month Momentum % | -23.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 11.55 | |||||
Forward Dividend Yield % | 10.98 | |||||
5-Year Yield-on-Cost % | 11.55 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -12.28 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Net Margin % | 90.55 | |||||
FCF Margin % | -15.64 | |||||
OCF Margin % | -15.64 | |||||
ROE % | 33.46 | |||||
ROA % | 17.98 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.48 | |||||
PE Ratio without NRI | 3.48 | |||||
PS Ratio | 2.72 | |||||
PB Ratio | 0.83 | |||||
Price-to-Tangible-Book | 0.83 | |||||
EV-to-Revenue | 2.3 | |||||
EV-to-FCF | -14.33 | |||||
Price-to-GF-Value | 6.45 | |||||
Price-to-Projected-FCF | 0.37 | |||||
FCF Yield % | -6.31 | |||||
Forward Rate of Return (Yacktman) % | 9.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Big Pharma Split Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.439 | ||
| EPS (TTM) (€) | -0.26 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 16.6 | ||
| 14-Day RSI | 44.79 | ||
| 14-Day ATR (€) | 0.102002 | ||
| 20-Day SMA (€) | 7.06 | ||
| 12-1 Month Momentum % | -23.53 | ||
| 52-Week Range (€) | 6.5 - 9.7 | ||
| Shares Outstanding (Mil) | 1.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Big Pharma Split Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Big Pharma Split Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| CAD 0.103100 Cash Dividend | 2025-09-29 | 7.10 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-08-29 | 7.30 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-07-31 | 7.35 (+6.52%) | ||
| CAD 0.103100 Cash Dividend | 2025-06-30 | 6.65 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-05-30 | 7.00 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-04-30 | 7.10 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-03-31 | 8.20 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-02-28 | 8.45 (+0.00%) | ||
| CAD 0.103100 Cash Dividend | 2025-01-31 | 8.85 (+4.12%) | ||
| CAD 0.103100 Cash Dividend | 2025-01-02 | 8.75 (+0.00%) |
Show
Entries
Big Pharma Split Corp Frequently Asked Questions
What is Big Pharma Split Corp(FRA:XN4)'s stock price today?
The current price of FRA:XN4 is €6.90. The 52 week high of FRA:XN4 is €9.70 and 52 week low is €6.50.
When is next earnings date of Big Pharma Split Corp(FRA:XN4)?
The next earnings date of Big Pharma Split Corp(FRA:XN4) is .
Does Big Pharma Split Corp(FRA:XN4) pay dividends? If so, how much?
The Dividend Yield %  of Big Pharma Split Corp(FRA:XN4) is 11.55% (As of Today), Highest Dividend Payout Ratio of Big Pharma Split Corp(FRA:XN4) was 0.78. The lowest was 0.35. And the median was 0.57. The  Forward Dividend Yield % of Big Pharma Split Corp(FRA:XN4) is 10.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Big Pharma Split Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers